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Further information 
Sendai virus vectors 
First-generation SeV vector: SeV wt genome carrying the reprogramming factors cDNA.  
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Second-generation SeV vectors: Some different SeV vectors were designed to avoid the 
dissemination of SeV vectors to the neighboring cells. To produce replication defective 
SeV vectors some viral essential genes were deleted.     
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ld: leader sequence 
tr: trailer sequence 
GS: Gene start 
UTR: Untranslated region 
GE: Gene end 
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Introduction 
Cellular reprogramming using vectors based on Sendai virus, which codifies for the 
reprogramming factors, is a non-integrative pathway to obtain iPSCs.  
Induced pluripotent stem cells (iPSCs) are an attractive tool for disease modelling and 
future therapeutic applications due to their unlimited proliferative capacity and the 
minimization of transplant rejections in patients.  
There are a wide range of methodologies to obtain iPSCs using cellular reprogramming 
factors. These methods can be integrative or non-integrative. The main problem of the 
integrative systems is the integration of the reprogramming factors genes into the cell 
genome. On the other hand, the major drawback of using non-integrative systems is the 
low efficiency of the process. 
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Using these vectors, iPSCs which have ability to rise to any cell type of the 
three germ layers were produced. This fact verifies the pluripotency of the 
obtained iPSCs.  
The employment of  SeV vectors enabled the efficient generation iPSCs.   
Reprogramming factors genes were not integrated into the genome of the 
target cells. For that reason, no risk of tumorigenesis has been related with 
this reprogramming method.  
1. iPSCs area is a promising candidate for research. The generation of patient 
iPSCs enables: 
 
• The study of pathogenic disease mechanism. 
• Preclinical drug screening. 
 
2. iPSCs are also attractive for therapeutic approaches such as cell therapy. 
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Objectives 
• Find out if the utilization of Sendai virus is an efficient non-integrating method to 
produce iPSCs.  
• Discuss if Sendai virus vectors could be employed to produce iPSCs, which are going 
to be used in regenerative medicine, in the future. 
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Materials and Methods 
• Scientific literature research on PubMed database: current papers and reviews of 
Sendai virus were selected according to their data of publications and quality. 
• Specialized books and reviews about Sendai virus and iPSCs.  
ssRNA 
RNA polymerase 
Sendai virus 
No human diseases related with SeV have been reported. 
Sendai virus (SeV) is a pleomorphic enveloped particle with a helical structure. Some 
promising features of SeV are as follows: 
SeV virus fulfils its lifecycle entirely in the cytoplasm of the infected cells without        
having a nuclear phase. Therefore, there is no danger of integration into the host 
genome. 
Could SeV be a good vector to produce iPSCs without risk of tumorigenesis? 
Some experimental approaches with different SeV vectors have been 
performed to investigate this hypothesis.  
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• The generation of iPSCs using SeV vectors is promising due to its efficiency.  
• There is no guarantee that the utilization of SeV vectors to produce iPSCs will be used 
in the future in regenerative medicine. The utilization of high temperatures to remove 
viral genomes may produce mutations or rearrangements in iPSCs; for that reason, 
more investigation is needed to check that cells do not mutate in these conditions. 
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